About
Psychedelics
Areas of Focus
Categories
PsychedelicBiotech
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
2
As Collaborator
0
Total Enrollment
279
By Phase
PHASE2: 2
By Status
COMPLETED: 2
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT05686239Lead Sponsor
A Study to Evaluate RL-007 in the Treatment of Cognitive Impairment Associated With Schizophrenia (CIAS)
PHASE2Completed
242 participants
Started: Dec 8, 2022 · Completed: Apr 9, 2025
NCT04822883Lead Sponsor
Safety, Biomarker Study of RL-007 in Subjects With Schizophrenia
PHASE2Completed
37 participants
Started: Apr 26, 2021 · Completed: Oct 28, 2021
Locations (1)
Headquarters
San Francisco, CA, United States
Map
Loading map...